Altamira Therapeutics Ltd. Amortisation Expense
Altamira Therapeutics Ltd. (CYTOF) reported Amortisation Expense of $597.27 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AmortisationExpense · last filed 2025-04-30
| Period end | Amortisation Expense 12 month |
|---|---|
| 2024-12-31 | $597.27K 20-F · filed 2025-04-30 |